President & CEO
Serge Maltais serves as President and CEO of Renaissance. With over 30 years of experience in managing operations and leading teams in the pharmaceutical space, he is adept at developing and implementing innovative solutions and achieving results. Previously, Serge served as President and CEO of Héma-Québec, a governmental non-profit organization that manages the supply of blood, human tissues, cord blood, and maternal milk throughout Quebec, Canada. Prior to that, Serge served as VP Supply Chain & Commercial Operations for Sandoz in Canada, and held positions of increasing responsibility within Manufacturing and Operations at Baxter. Serge holds a Bachelor of Industrial Engineering from École Polytechnique in Montréal, as well as a Diploma in Business Administration from Université de Sherbrooke, Sherbrooke.
Robert Harrer serves as the CFO of Renaissance. He has over 25 years of experience in financial management, with a strong operational focus in the specialty chemicals and pharmaceutical industry. Previously, he served as CFO at Avantor and Innophos, and held various financial leadership positions at Rohm and Haas. He is a member of the board of directors of KMG Chemicals.
Mr. Harrer received his master of business administration and mathematics from Albert Einstein University in Ulm, Germany.
Alain Carrier joined Renaissance in November 2012 after spending 8 years at Sandoz and Sabex. Most recently, he served as Vice President, Development and Registration for the global development center for sterile products based in Canada. Under his leadership, the Sandoz Center of Excellence filed nearly 100 ANDA’s, many being Paragraph IV patent certifications and first to files. Mr. Carrier also acted as Functional Lead of the global analytical development team.
Prior to his tenure at Sandoz, Mr. Carrier held senior scientific positions at Caprion Pharmaceuticals, RTP Pharma, and Phoenix International Life Sciences.
Mr. Carrier has an undergraduate degree in Chemistry and a Ph.D. in Analytical Chemistry from the University of Montreal.
Brenda Vesey serves as the VP – CHRO for Renaissance. She has over 25 years of experience in HR across multiple industries. She has served on a number of Executive Leadership teams and has held a variety of HR leadership roles within the pharmaceutical industry including roles at Teva Pharmaceuticals, Allergan, Actavis, and Alpharma. Prior to that she worked for Toys “R” Us and Chase Manhattan Corporation. While at Chase she worked in both Financial Operations and Human Resources.
Brenda is a graduate of Siena College in Loudonville, NY, where she earned a B.S. degree in Economics.
VP, Business Development
Julie Simon serves as the VP of Business Development for Renaissance. She has over 15 years of management experience in the pharmaceutical industry, with a history of success in identifying & executing unique business opportunities, organizational transformation, and value creation. Ms. Simon previously held leadership positions with Ben Venue/Bedford Laboratories, Akorn, APP/Abraxis, Bioniche Pharma and Mylan. Her experience spans commercial, operational and technical verticals, with focus on Business Development, M&A, Commercial Operations, R&D, Strategic Sourcing and Quality.
VP, Regulatory Affairs
Kimberly Ernst serves as the Vice President of Regulatory Affairs. Kim is a seasoned leader with 15 years of experience in the pharmaceutical industry. She has deep experience in preparing regulatory submissions, strategizing effective regulatory pathways, and developing innovative approaches. Before joining Renaissance Kim worked at Impax Laboratories (via CorePharma acquisition) as the Senior Director, Regulatory Affairs. Prior to Impax she worked in roles of increasing responsibility at Dr. Reddy’s Laboratories, B. Braun Medical Inc, and Teva Pharmaceuticals.
Kim holds a B.S. in Chemistry from Cedar Crest College and an M.S. in Chemistry from Lehigh University.
Antonio Di Nicola
Antonio Di Nicola serves as the Plant Manager of the Renaissance Lakewood sterile manufacturing facility, and has over 28 years of experience in managing and directing functional teams engaged in the aseptic manufacturing process of parenterals. His successes include managing and implementing several initiatives to increase efficiencies and plant productivity.
Before joining Renaissance, Mr. Di Nicola has held positions of increased responsibility, which include Director of Operations at West-Ward Pharmaceuticals, Associate Director of Manufacturing at Baxter Healthcare, and Manager of Product Compliance at Wyeth-Ayerst.
Sr. Director, Commercial Operations
Bob Rodowicz serves as Sr. Director, Commercial Operations where he is responsible for the commercial infrastructure and customer relationships to grow the US generic business at Renaissance. Prior to joining Renaissance, Bob held increasing Sales and Marketing roles at Micro Labs, Dr. Reddy’s, Zydus, and Sandoz that have helped him develop a well-balanced mindset and understanding of the ever-changing US generic marketplace.
William J. Graham
Sr. Director, Quality Systems
William J. Graham serves as the Sr. Director, Quality Systems for Renaissance, and has over 30 years of experience in managing and directing functional and cross functional teams engaged in the aseptic manufacturing process of parenterals. He has extensive experience with aseptic processing, validations, quality systems, compliance inspections and manufacturing.
Before joining Renaissance, Bill was the Sr. Director of Quality Operations, Director of Technical Services and Director of Manufacturing with Wyeth, Baxter Healthcare and West-Ward Pharmaceuticals.